ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 423,67
0,20%
Dow Jones
42 518,28
0,52%
DAX
20 271,33
0,67%
Brent Oil
79,595
-0,13%
Bitcoin
97 263,62
0,79%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. BioCardia Inc (BCDA) Cours

BioCardia Inc

BioCardia Inc (BCDA)

NASDAQ
2,16
-0,09
(-4,00%)
Fermé 15 Janvier 10:00PM
Retardé de 15 minutes
2,16
0,00
(0,00%)
Après les heures de négociation: 1:00AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
2,16
Prix Achat
2,01
Prix Vente
2,38
Volume échangé
74 562
2,1004 Fourchette du Jour 2,36
1,625 Plage de 52 semaines 9,90
Cap du marché
9,902M
Clôture Veille
2,25
Ouverture
2,26
Dernière Transaction
10
@
2.16
Dernière heure de transaction
Volume financier
US$ 164 788
VWAP
2,2101
Volume moyen (3 m)
47 674
Actions en circulation
4 584 285
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,86
Bénéfice par action (BPA)
-2,52
Chiffre d'affairess
477k
Bénéfice net
-11,57M

À propos de BioCardia Inc

BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus o... BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus on heart failure resulting from a heart attack. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.biocardia.com
Siège social
Wilmington, Delaware, USA
Fondé
-
BioCardia Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker BCDA. Le dernier cours de clôture d'BioCardia était de US$2,25. Au cours de la dernière année, les actions de BioCardia ont été négociées dans une fourchette de prix de US$ 1,625 à US$ 9,90.

BioCardia compte actuellement 4 584 285 actions en circulation. La capitalisation boursière d'BioCardia est de US$10,31 million. BioCardia a un ratio cours/bénéfice (ratio PE) de -0.86.

BCDA Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

26 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

26 Décembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

17 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

17 Décembre 2024
Edgar (US Regulatory)

BioCardia Announces Commercial Availability of Morph® DNA™ Steerable Introducer Product Family

SUNNYVALE, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...

17 Décembre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

09 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

04 Décembre 2024
Edgar (US Regulatory)

BioCardia Announces Positive Consultation with Japan PMDA on CardiAMP Cell Therapy for Ischemic Heart Failure

SUNNYVALE, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...

04 Décembre 2024
GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]

02 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

19 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.255-10.55900621122.4152.451.985388802.23923629CS
40.062.857142857142.12.48141.625537592.18473601CS
12-0.49-18.49056603772.652.761.625476742.24870001CS
26-1.02-32.07547169813.184.661.6254461123.56394105CS
52-7.4415-77.50351507589.60159.91.6253730794.43337244CS
156-23.64-91.627906976725.843.79851.62554031617.80841782CS
260-77.19-97.277882797779.351291.62555431241.77631856CS

BCDA - Frequently Asked Questions (FAQ)

What is the current BioCardia share price?
The current share price of BioCardia is US$ 2,16
How many BioCardia shares are in issue?
BioCardia has 4 584 285 shares in issue
What is the market cap of BioCardia?
The market capitalisation of BioCardia is USD 10,31M
What is the 1 year trading range for BioCardia share price?
BioCardia has traded in the range of US$ 1,625 to US$ 9,90 during the past year
What is the PE ratio of BioCardia?
The price to earnings ratio of BioCardia is -0,86
What is the cash to sales ratio of BioCardia?
The cash to sales ratio of BioCardia is 20,75
What is the reporting currency for BioCardia?
BioCardia reports financial results in USD
What is the latest annual turnover for BioCardia?
The latest annual turnover of BioCardia is USD 477k
What is the latest annual profit for BioCardia?
The latest annual profit of BioCardia is USD -11,57M
What is the registered address of BioCardia?
The registered address for BioCardia is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the BioCardia website address?
The website address for BioCardia is www.biocardia.com
Which industry sector does BioCardia operate in?
BioCardia operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
HEESH and E Equipment Services Inc
US$ 90,29
(105,48%)
13,29M
AIFFFirefly Neuroscience Inc
US$ 3,11
(63,68%)
131,28M
RGTIRigetti Computing Inc
US$ 8,94
(47,77%)
354,95M
ERNAEterna Therapeutics Inc
US$ 0,452561
(46,46%)
575,5M
TDUPThredUp Inc
US$ 1,88
(44,62%)
13,53M
WNWMeiwu Technology Company Ltd
US$ 1,00
(-66,67%)
12,78M
PHIOPhio Pharmaceuticals Corporation
US$ 3,5707
(-45,90%)
11,23M
MBIOMustang Bio Inc
US$ 0,1434
(-35,95%)
15,3M
BDMDBaird Medical Investment Holdings Ltd
US$ 7,695
(-30,74%)
493,77k
ATPCAgape ATP Corporation
US$ 1,3904
(-29,42%)
1,26M
ERNAEterna Therapeutics Inc
US$ 0,452561
(46,46%)
575,5M
RGTIRigetti Computing Inc
US$ 8,94
(47,77%)
354,95M
NVDANVIDIA Corporation
US$ 131,76
(-1,10%)
195,58M
GCTKGlucoTrack Inc
US$ 0,1216
(-18,77%)
172,89M
NMHINatures Miracle Holding Inc
US$ 1,5106
(33,68%)
167,17M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
BCDA
BioCardia
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés